NDC 13668-092 – Pramipexole Dihydrochloride
Pramipexole Dihydrochloride .25 mg/1 · Tablet · Oral
Product NDC13668-092
Product details
- Brand name
- Pramipexole Dihydrochloride
- Generic name
- Pramipexole Dihydrochloride
- Labeler
- Torrent Pharmaceuticals Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA090865
- Marketed since
- October 8, 2010
- Listing expires
- December 31, 2027
- Pharmacologic class
- Nonergot Dopamine Agonist
Active ingredients
- Pramipexole Dihydrochloride .25 mg/1
Uses, dosage, side effects and warnings for pramipexole dihydrochloride →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 13668-092-05 | 500 TABLET in 1 BOTTLE (13668-092-05) | Oct 8, 2010 |
| 13668-092-30 | 30 TABLET in 1 BOTTLE (13668-092-30) | Oct 8, 2010 |
| 13668-092-41 | 5500 TABLET in 1 BOTTLE (13668-092-41) | Oct 8, 2010 |
| 13668-092-90 | 90 TABLET in 1 BOTTLE (13668-092-90) | Oct 8, 2010 |
Other pramipexole dihydrochloride products
- 50090-7816 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · A-S Medication Solutions
- 50090-2455 Pramipexole Dihydrochloride .5 mg/1 · Tablet · A-S Medication Solutions
- 50090-3280 Pramipexole Dihydrochloride .25 mg/1 · Tablet · A-S Medication Solutions
- 50090-5036 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · A-S Medication Solutions
- 62332-003 Pramipexole Dihydrochloride .125 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-156 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-005 Pramipexole Dihydrochloride .5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-007 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-006 Pramipexole Dihydrochloride 1 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-155 Pramipexole Dihydrochloride .75 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-004 Pramipexole Dihydrochloride .25 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-154 Pramipexole Dihydrochloride .375 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.